Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 874067, 6 pages
http://dx.doi.org/10.1155/2015/874067
Research Article

Medication Lists and Brown Bag Reviews: Potential Positive and Negative Impacts on Patients Beliefs about Their Medicine

1Department of General Practice and Health Services Research, University Hospital Heidelberg, Voßstraße 2, Geb. 37, 69115 Heidelberg, Germany
2Institute of Family Medicine, University Hospital Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, Haus 50, 23538 Lübeck, Germany

Received 22 May 2015; Accepted 3 September 2015

Academic Editor: Anna Giardini

Copyright © 2015 Cornelia Jäger et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Salisbury, L. Johnson, S. Purdy, J. M. Valderas, and A. A. Montgomery, “Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study,” British Journal of General Practice, vol. 61, no. 582, pp. e12–e21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. R. A. Hansen, C. I. Voils, J. F. Farley et al., “Prescriber continuity and medication adherence for complex patients,” Annals of Pharmacotherapy, vol. 49, no. 3, pp. 293–302, 2015. View at Publisher · View at Google Scholar
  3. K. M. Hakkarainen, K. Hedna, M. Petzold, and S. Hägg, “Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions—a meta-analysis,” PLoS ONE, vol. 7, no. 3, Article ID e33236, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. H. J. M. Beijer and C. J. de Blaey, “Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies,” Pharmacy World and Science, vol. 24, no. 2, pp. 46–54, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Burgdorf and L. Sundmacher, “Potentially avoidable hospital admissions in Germany: an analysis of factors influencing rates of ambulatory care sensitive hospitalizations,” Deutsches Arzteblatt International, vol. 111, no. 13, pp. 215–223, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Morimoto, T. K. Gandhi, A. C. Seger, T. C. Hsieh, and D. W. Bates, “Adverse drug events and medication errors: detection and classification methods,” Quality & Safety in Health Care, vol. 13, no. 4, pp. 306–314, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Avery, N. Barber, M. Ghaleb et al., “Investigating the prevalence and causes of prescribing errors in general practice: The Practice Study (Prevalence and Causes of prescribing errors in general practice). A report for the GMC,” 2012, http://www.gmc-uk.org/Investigating_the_prevalence_and_causes_of_prescribing_errors_in_general_practice___The_PRACtICe_study_Reoprt_May_2012_48605085.pdf.
  8. J. Y. F. Wu, W. Y. S. Leung, S. Chang et al., “Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial,” British Medical Journal, vol. 333, no. 7567, p. 522, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Burkhardt, M. Wehling, and R. Gladisch, “Prevention of adverse drug reactions in older patients,” Zeitschrift fur Gerontologie und Geriatrie, vol. 40, no. 4, pp. 241–254, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Linden, H. Gothe, and J. Ormel, “Pathways to care and psychological problems of general practice patients in a ‘gate keeper’ and an ‘open access’ health care system: a comparison of Germany and the Netherlands,” Social Psychiatry and Psychiatric Epidemiology, vol. 38, no. 12, pp. 690–697, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Bergk, C. Gasse, R. Schnell, and W. E. Haefeli, “Requirements for a successful implementation of drug interaction information systems in general practice: results of a questionnaire survey in Germany,” European Journal of Clinical Pharmacology, vol. 60, no. 8, pp. 595–602, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Y. Chae, M. H. Chae, N. Isaacson, and T. S. James, “The patient medication list: can we get patients more involved in their medical care?” Journal of the American Board of Family Medicine, vol. 22, no. 6, pp. 677–685, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. W. E. Haefeli, “Polypharmacy and drug therapy in elderly patients—a balance between application, adaptation and discontinuing medication,” Klinikarzt, vol. 43, no. 9, pp. 406–411, 2014. View at Publisher · View at Google Scholar
  14. “Action Alliance ‘Safe Mddication Use’ of the Rhein-Neckar-Region/Heidelberg. Results of a survey among 5340 citizens,” 2015, http://nimmsrichtig.de/downloads/presse/34_PK_Aktionsbuendnis_Sichere_Arzneimittelanwendung.pdf.
  15. M. J. Aylward, T. Rogers, and P. G. Duane, “Inaccuracy in patient handoffs: discrepancies between resident-generated reports and the medical record,” Minnesota medicine, vol. 94, no. 12, pp. 38–41, 2011. View at Google Scholar · View at Scopus
  16. J. Balon and S. A. Thomas, “Comparison of hospital admission medication lists with primary care physician and outpatient pharmacy lists,” Journal of Nursing Scholarship, vol. 43, no. 3, pp. 292–300, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Ekedahl, H. Brosius, J. Jönsson, H. Karlsson, and M. Yngvesson, “Discrepancies between the electronic medical record, the prescriptions in the Swedish national prescription repository and the current medication reported by patients,” Pharmacoepidemiology and Drug Safety, vol. 20, no. 11, pp. 1177–1183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. L. R. Tulner, I. M. J. A. Kuper, S. V. Frankfort et al., “Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions,” The American Journal Geriatric Pharmacotherapy, vol. 7, no. 2, pp. 93–104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Q. J. Freigofas, J. Kaltschmidt, and W. E. Haefeli, Medication Lists in Daily Use—Requirements, Benefits and the Sobering Results Seen in Reality, edited by F. Duesberg and G. Hellmann, e-Health, Solingen, Germany, 2014.
  20. R. S. Joanne Shaw and M. Pilling, Room for Review—A Guide to Medication Review: The Agenda for Patients, Practitioners and Managers: Task Force on Medicines Partnership and The National Collaborative Medicines Management Services Programme, 2002, http://myweb.tiscali.co.uk/bedpgme/CG/Room%20for%20Review%20-%20Medication%20review.pdf.
  21. Primary care guideline for multimedication developed by the German College of General Practitioners and Family Physicians (DEGAM): [Recommendations for the treatment of multimedication in adult and elderly patients], 2015, http://www.pmvforschungsgruppe.de/pdf/03_publikationen/multimedikation_ll.pdf.
  22. C. Mahler, T. Freund, A. Baldauf et al., “Structured medication management in primary care—a tool to promote medication safety,” Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, vol. 108, no. 5-6, pp. 258–269, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Jäger, T. Freund, J. Steinhäuser, S. Joos, M. Wensing, and J. Szecsenyi, “A tailored implementation intervention to implement recommendations addressing polypharmacy in multimorbid patients: study protocol of a cluster randomized controlled trial,” Trials, vol. 14, no. 1, article 420, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Altiner, I. Schäfer, C. Mellert et al., “Activating GENeral practitioners dialogue with patients on their agenda (MultiCare AGENDA) study protocol for a cluster randomized controlled trial,” BMC Family Practice, vol. 13, article 118, 2012. View at Publisher · View at Google Scholar
  25. R. Horne, J. Weinman, and M. Hankins, “The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication,” Psychology and Health, vol. 14, no. 1, pp. 1–24, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Mahler, K. Hermann, R. Horne, S. Jank, W. E. Haefeli, and J. Szecsenyi, “Patients' beliefs about medicines in a primary care setting in Germany,” Journal of Evaluation in Clinical Practice, vol. 18, no. 2, pp. 409–413, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. E. C. Lehnbom, M. J. Stewart, E. Manias, and J. I. Westbrook, “Impact of medication reconciliation and review on clinical outcomes,” Annals of Pharmacotherapy, vol. 48, no. 10, pp. 1298–1312, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Jager, J. Szecsenyi, T. Freund et al., “Developing a tailored intervention: implementing recommendations for polypharmacy in multimorbid patients (PomP),” Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, vol. 108, no. 5-6, pp. 270–277, 2014. View at Publisher · View at Google Scholar
  29. C. Jäger, J. Szecsenyi, and J. Steinhäuser, “Design and delivery of a tailored intervention to implement recommendations for multimorbid patients receiving polypharmacy into primary care practices,” BioMed Research International, vol. 2015, Article ID 938069, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Horne, S. C. E. Chapman, R. Parham, N. Freemantle, A. Forbes, and V. Cooper, “Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework,” PLoS ONE, vol. 8, no. 12, Article ID e80633, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. O. von dem Knesebeck, H. Bickel, A. Fuchs et al., “Social inequalities in patient-reported outcomes among older multimorbid patients—results of the MultiCare cohort study,” International Journal for Equity in Health, vol. 14, no. 1, article 17, 2015. View at Publisher · View at Google Scholar